TriSalus Life Sciences In...

NASDAQ: TLSI · Real-Time Price · USD
4.26
0.38 (9.79%)
At close: Aug 15, 2025, 12:29 PM

TriSalus Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.05M -59.04M -47.19M -28.84M
Depreciation & Amortization
744K 684K 398K 464K
Stock-Based Compensation
5.44M 1.4M 368K 109K
Other Working Capital
-1.94M 751K -2.57M -1.84M
Other Non-Cash Items
-7.43M 6.37M 11.5M 6.54M
Deferred Income Tax
n/a n/a 310K -832K
Change in Working Capital
-9.55M 537K 2.3M -131K
Operating Cash Flow
-40.84M -50.05M -32.31M -22.7M
Capital Expenditures
-345K -588K -786K -1.26M
Cash Acquisitions
n/a -1M -1M -1M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -533K n/a n/a
Investing Cash Flow
-345K -2.12M -1.79M -2.26M
Debt Repayment
24.92M -87K -131K -1.3M
Common Stock Repurchased
n/a -20K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.52M 45.53M 94K 54K
Financial Cash Flow
37.94M 54.63M 13.46M 50.77M
Net Cash Flow
-3.25M 2.46M -20.64M 25.81M
Free Cash Flow
-41.19M -51.17M -33.1M -23.95M